BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26480769)

  • 1. [Autoimmune cerebellar ataxia].
    Nanri K; Okuma M; Sato S; Taguchi T; Tanaka N
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():632-7. PubMed ID: 26480769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
    Mitoma H; Nanri K
    Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment.
    Nociti V; Frisullo G; Tartaglione T; Patanella AK; Iorio R; Tonali PA; Batocchi AP
    Eur J Neurol; 2010 Jan; 17(1):e5. PubMed ID: 19906270
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis.
    Poorthuis MHF; van Rooij JLM; Koch AH; Verdonkschot AEM; Leembruggen MM; Titulaer MJ
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e579. PubMed ID: 31355315
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive hearing loss and cerebellar ataxia in anti-Ma2-associated autoimmune encephalitis.
    Souza PV; Bortholin T; Pinto WB; Santos AJ
    Arq Neuropsiquiatr; 2017 Jan; 75(1):74-75. PubMed ID: 28099568
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Rouco I; Hurtado P; Castaño L; Zarranz JJ
    Neurologia; 2015 May; 30(4):247-9. PubMed ID: 24075582
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autoimmune encephalitis. New diagnosis for an old condition].
    Caparó Oblitas RL
    Medicina (B Aires); 2018; 78 Suppl 2():88-93. PubMed ID: 30199372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.
    Villa SM; Rufa A; Malandrini A; Cerase A; Rosini F; Arrigucci U; Federico A
    Neurol Sci; 2019 Jun; 40(6):1303-1306. PubMed ID: 30635801
    [No Abstract]   [Full Text] [Related]  

  • 11. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
    Pedroso JL; Braga-Neto P; Dutra LA; Barsottini OG
    Arq Neuropsiquiatr; 2011 Dec; 69(6):993. PubMed ID: 22297896
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy in autoimmune encephalitis - A need for "presumptive" diagnosis and treatment.
    Pradhan S; Das A; Mani VE
    Neurol India; 2018; 66(6):1584-1589. PubMed ID: 30504544
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: a case series.
    Incecik F; Herguner OM; Besen S; Yılmaz M
    Acta Neurol Belg; 2018 Sep; 118(3):411-414. PubMed ID: 29349679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of anti-gliadin-antibody-positive cerebellar ataxia effectively treated with intravenous immunoglobulin in which voxel-based morphometry and FineSRT were diagnostically useful].
    Nanri K; Otsuka T; Takeguchi M; Taguchi T; Ishiko T; Mitoma H; Koizumi K
    Rinsho Shinkeigaku; 2009 Jan; 49(1):37-42. PubMed ID: 19227895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent response to steroid treatment in anti-GAD cerebellar ataxia.
    Lauria G; Pareyson D; Pitzolu MG; Bazzigaluppi E
    Lancet Neurol; 2003 Oct; 2(10):634-5. PubMed ID: 14505586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cerebellar Ataxia and Autoantibodies].
    Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
    Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
    Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
    Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoimmune encephalopathy].
    Holmøy T
    Tidsskr Nor Laegeforen; 2010 May; 130(10):1043. PubMed ID: 20489808
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
    Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
    Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.